CLINICAL TRIALS PROFILE FOR PATANASE
✉ Email this page to a colleague
All Clinical Trials for PATANASE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00789555 ↗ | Safety of PATANASE Nasal Spray in Patients With Perennial Allergic Rhinitis | Completed | Alcon Research | Phase 4 | 2008-11-01 | The purpose of this study was to assess local nasal adverse effects, as well as systemic effects, of PATANASE nasal spray when compared with Patanase Vehicle, pH 3.7 and Patanase Vehicle, pH 7.0 in patients with perennial allergic rhinitis (PAR). |
| NCT00794144 ↗ | Safety and Pharmacokinetics of Patanase in Pediatric Patients 2 to < 6 Years of Age | Completed | Alcon Research | Phase 2 | 2008-10-01 | The purpose of the study is to assess the safety of the study drug, Patanase (Olopatadine Hydrochloride Nasal Spray 0.6%) compared to placebo (inactive substance) in children ages 2 to less than 6 who have a history of nasal allergies, and to assess the pharmcokinetics (study of the action of a drug in the body) in these children |
| NCT00979615 ↗ | Safety and Efficacy of Olopatadine 0.6% and Azelastine 137 Mcg in Vasomotor Rhinitis | Completed | Alcon Research | Phase 4 | 2009-09-01 | The purpose of this study is to examine safety and efficacy of Patanase and Astelin in treating the symptoms of non-allergic vasomotor rhinitis (VMR). |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PATANASE
Condition Name
Clinical Trial Locations for PATANASE
Trials by Country
Clinical Trial Progress for PATANASE
Clinical Trial Phase
Clinical Trial Sponsors for PATANASE
Sponsor Name
